Death Receptor 5 (TNFRSF10B) Is Upregulated and TRAIL Resistance Is Reversed in Hypoxia and Normoxia in Colorectal Cancer Cell Lines after Treatment with Skyrin, the Active Metabolite of Hypericum spp.

CANCERS

Babincak, M; Jendzelovsky, R; Kosuth, J; Majernik, M; Vargova, J; Mikulasek, K; Zdrahal, Z; Fedorocko, P, 2021: Death Receptor 5 (TNFRSF10B) Is Upregulated and TRAIL Resistance Is Reversed in Hypoxia and Normoxia in Colorectal Cancer Cell Lines after Treatment with Skyrin, the Active Metabolite of Hypericum spp.. CANCERS 13(7), doi: 10.3390/cancers13071646

Research Groups:

CEITEC authors: